Purchases and Sales Made in Q1 2023 in Evoke Pharma Inc (EVOK)
This table provides information about the institutional ownership of Evoke Pharma Inc (EVOK) during Q1 2023. The information is specifically focused on institutions that hold shares of Evoke Pharma Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
11.2KNew |
$21.1K - $64.3K
|
11.2K
$5.25K
|
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.13K+ 367.17% |
$5.92K - $18K
|
3.99K
$1.87K
|
|
|
Apr 26, 2023
Q1 2023
|
Concord Wealth Partners
|
BUY
|
- |
114New |
$215 - $656
|
114
$53.6
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
6+ 27.27% |
$11.3 - $34.5
|
28
$13.2
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-6.32K- 81.1% |
$11.9K - $36.3K
|
1.47K
$692
|